Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|November 30, 2012
Serum receptor activator of nuclear factor-κ B ligand, osteoprotegrin, and intact parathyroid hormone in hemodialysis and renal transplant patientsNadereh Rashtchizadeh, Amir Ghorbanihaghjo, Hassan Argani, et al.
Clinical Biochemistry|August 24, 2010
Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathyNariman Nezami, Javid Safa, Amir Taher Eftekhar-Sadat, et al.
Journal of Health, Population, and Nutrition|December 3, 2013
Protective effect of fish oil supplementation on DNA damage induced by cigarette smokingAmir Ghorbanihaghjo, Javid Safa, Samira Alizadeh, et al.
Clinical Biochemistry|October 26, 2010
Lovastatin enhances paraoxonase enzyme activity and quells low-density lipoprotein susceptibility to oxidation in type 2 diabetic nephropathyNariman Nezami, Amir Ghorbanihaghjo, Hassan Argani, et al.
Clinical and Experimental Nephrology|January 5, 2008
Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphismsAmir Ghorbanihaghjo, Pegah Veisi, Hassan Argani, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|January 16, 2008
Calcium and phosphorus metabolism in stable renal transplant recipientsHamid T Khosroshahi, Mohammadali M Shoja, Sima Abedi Azar, et al.
Iranian Journal of Kidney Diseases|September 21, 2010
Protective effect of grape seed extract on gentamicin-induced acute kidney injuryJavid Safa, Hassan Argani, Bahar Bastani, et al.
Nucleosides, Nucleotides & Nucleic Acids|March 27, 2012
Effect of lovastatin therapy and withdrawal on serum uric acid level in people with type 2 diabetic nephropathyNariman Nezami, Javid Safa, Behzad Salari, et al.
Iranian Journal of Kidney Diseases|June 1, 2014
Lovastatin for reduction of leptin in nondialysis patients with type 2 diabetic nephropathySharareh Gholamin, Seyed-Mostafa Razavi, Seyed-Meghdad Taghavi-Garmestani, et al.
Nephron|March 8, 2018
The Relationship between Carotid and Femoral Artery Intima-Media Thickness and Histopathologic Grade of Atherosclerosis in Patients with Chronic Kidney DiseaseNariman Nezami, Kamyar Ghabili, Behrooz Shokouhi-Gogani, et al.
Pageof 3